274 filings
6-K
BNTX
BioNTech SE
22 Mar 24
Current report (foreign)
5:33pm
6-K
BNTX
BioNTech SE
20 Mar 24
BioNTech Announces Fourth Quarter and Full Year 2023
7:33am
6-K
BNTX
BioNTech SE
20 Mar 24
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
7:11am
6-K
BNTX
BioNTech SE
11 Mar 24
BioNTech to Present Clinical Data Updates For Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
9:04am
6-K
BNTX
BioNTech SE
7 Mar 24
BioNTech Announces Planned Retirement of Sean Marett
8:41am
6-K
s62qy00fpfvciwc ktru
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:08am
6-K
p99d6vr9p14pms0a
31 Jan 24
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
7:47am
6-K
nvngx2ijloz4 py
22 Jan 24
Current report (foreign)
9:14am
6-K
jalfj8e6 6ac4a
9 Jan 24
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
7:01am
6-K
u8hfkuste6n
21 Dec 23
BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer
4:02pm
6-K
6whgi8mjwfhfm7m9
18 Dec 23
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
4:22pm
6-K
pybzzbh 5c
7 Dec 23
BioNTech and Australia’s State of Victoria Sign Agreement on Strategic Partnership to Strengthen mRNA Ecosystem
8:17pm
6-K
b86bnfnu36c hg73
7 Nov 23
1 Welcome & Introductory Remarks Ryan Richardson Chief Strategy Officer
8:03am
6-K
93dqboh jhcuf
6 Nov 23
Current report (foreign)
6:54am
6-K
4jski
6 Nov 23
BioNTech Announces Third Quarter 2023 Financial Results
6:52am
6-K
sqey 0v4oz7mjosam
26 Oct 23
Pfizer and BioNTech Announce Positive Topline Data for Influenza and COVID-19
4:08pm
6-K
wmv3jh2mym8lc iq69u
23 Oct 23
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
4:16pm
6-K
rlma qud7
16 Oct 23
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
6:14am
6-K
3fyekp9h uz
16 Oct 23
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
6:03am
6-K
qdcfw2
11 Sep 23
Current report (foreign)
4:03pm